U.S. Beverage Stock News

InMode (INMD) has introduced a new US$ share repurchase program, authorizing the buyback of up to 6,380,000 shares, or about 10% of its outstanding stock, using available cash. See our latest analysis for InMode. The buyback news comes after a mixed stretch for investors, with a 1-day share price return of 6.11% and a 7-day share price return of 2.34% contrasting with a year-to-date share price return decline of 8.51% and a 1-year total shareholder return decline of 26.05%. This suggests that...

If you are wondering whether Aeva Technologies' current share price lines up with its real value, you are not alone. This article is here to unpack that question step by step. The stock last closed at US$15.16, with returns of 7.0% over 7 days, 19.0% over 30 days, 18.9% year to date, a very large 1 year return that sits well above 400%, a 3 year return of 84.9%, and a 5 year return of a 79.2% decline. These moves have put Aeva back on many watchlists, as investors reassess how the market is...

If you are wondering whether Coca-Cola FEMSA. de is still offering fair value at around US$97.16 per share, this article will walk through what the current price might be implying about the business. The stock has seen mixed recent returns, with a 6.8% decline over the past week and a 13.7% decline over the last month, set against longer term returns of 2.4% year to date, 13.6% over 1 year, 45.3% over 3 years and 154.2% over 5 years. Recent attention around Coca-Cola FEMSA. de has centered...

If you are wondering whether Hyatt Hotels' share price still reflects good value, or if you are late to the story, this article will walk through what the numbers say about the stock today. Hyatt last closed at US$139.30, with a 6.9% decline over 7 days and a 17.4% decline over 30 days, while the stock shows a 14.4% return over 1 year, 33.0% over 3 years and 62.2% over 5 years. Recent headlines around Hyatt have focused on its ongoing position as a global hotel operator and the broader...

Dyne Therapeutics plans to submit an accelerated application for its Duchenne muscular dystrophy drug, targeting a potential commercial launch in early 2027. The company has completed enrollment in its Phase 1/2 trial in myotonic dystrophy type 1 and started a Phase 3 trial for DYNE-101 in DM1. New long term DELIVER trial data report meaningful improvements in lung and cardiac function in patients with Duchenne muscular dystrophy. For investors watching NasdaqGS:DYN, these clinical and...

If you are wondering whether Sally Beauty Holdings is still worth your attention at around US$14.54 per share, this article walks through what that price could mean for value focused investors. The stock is roughly flat year to date with a 0.3% return. However, the 59.4% return over the past year, alongside shorter term moves of a 1.7% decline over 7 days and a 4.5% decline over 30 days, suggests sentiment has shifted more than once recently. Recent coverage has focused on Sally Beauty...

In recent updates, Landstar System expanded its heavy haul and Mexico cross-border services while maintaining dividends, share repurchases, and a lower long-term debt load. This combination of operational expansion and financial conservatism contrasts with softer freight demand and capacity imbalances that have led analysts to trim earnings expectations. Now we’ll explore how analysts’ cautious earnings revisions, despite Landstar’s heavy haul and Mexico expansion, reshape the company’s...

Kadant stock moves: how recent returns stack up for long term holders Kadant (KAI) has seen mixed share performance recently, with a 5.5% decline over the past day and about 9.3% over the past month, while the past 3 months show a 3.9% gain. See our latest analysis for Kadant. Zooming out from the recent pullback, Kadant’s 1-day and 30-day share price returns of 5.5% and 9.3% declines contrast with a 6% year to date gain and a 56.2% three year total shareholder return. This suggests momentum...

In recent days, analysts at Canaccord Genuity and Stifel reiterated positive views on Artivion, highlighting the aortic disease pipeline and particularly the NEXUS stent graft system after one-year trial data showed strong sealing and low endoleak rates, with physicians indicating plans to adopt the device if it receives FDA approval. This combination of supportive clinical evidence and physician interest underscores how Artivion’s pipeline products could strengthen its position in treating...

In recent days, Magnolia Oil & Gas reported an 11% increase in proved developed producing reserves, fourth-quarter net income of US$71.4 million, and year-on-year production growth to 103,800 barrels of oil equivalent per day. At the same time, insider share sales and a new 52-week high coincided with analysts highlighting Magnolia’s stronger reserve base and operational efficiency amid shifting geopolitical conditions for oil markets. We’ll now examine how Magnolia’s improved reserves and...

In March 2026, Bumble reported fourth-quarter 2025 results that exceeded revenue and earnings expectations, issued first-quarter 2026 revenue guidance of US$209 million to US$213 million (including US$171 million to US$174 million from the Bumble app), and highlighted stronger profitability despite fewer paying users. The company also unveiled an AI-powered overhaul, including its Bee model, the Dates assistant and the upcoming Bumble 2.0 cloud-native platform, aiming to improve user...

Why Perrigo’s UBS conference appearance is drawing fresh attention Perrigo (PRGO) is set to present at the UBS Global Consumer and Retail Conference in New York on March 11, 2026, with President and CEO Patrick Lockwood-Taylor scheduled to speak. The event has put a fresh spotlight on the stock, as investors look for updated commentary on Perrigo’s over the counter health and wellness portfolio, recent financial results, and how management is thinking about capital allocation. See our latest...

If you are looking at Humana and wondering whether the recent share price puts it in bargain territory or not, it helps to start with the facts behind the current valuation story. Humana's share price most recently closed at US$165.43, with returns of a 7.7% decline over 7 days, a 5.7% decline over 30 days, a 37.5% decline year to date, a 33.7% decline over 1 year, a 65.5% decline over 3 years, and a 57.7% decline over 5 years. Recent headlines around Humana have focused on how the share...

If you are wondering whether Knight-Swift Transportation Holdings is attractively priced today, you are not alone. Its recent share performance has put valuation questions front and center. The stock last closed at US$51.93, with a 7 day return of an 8.7% decline, a 30 day return of a 13.8% decline and a 1 year return of 13.3%, which gives mixed signals on how the market is treating the company right now. Recent news around Knight-Swift has focused on its position in the US trucking and...

Warrior Met Coal recently began commercial-scale mining at its Blue Creek project ahead of schedule, which has already started to influence revenue and cash flow expectations based on higher production capacity. This early ramp-up at Blue Creek is reshaping views on the company’s future operations, including potential shifts in capital spending needs and shareholder cash distributions. Next, we’ll explore how the ahead-of-schedule Blue Creek commercial production may affect Warrior Met...

If you are wondering whether Amentum Holdings at US$27.90 is offering fair value or an opportunity, you are not alone in asking what the current price really reflects. The stock has seen a mixed return profile, with a 7% decline over the last week and an 8.2% decline over the last month, while still sitting on a 55.9% return over the past year and an 8.5% decline year to date. Recent news coverage around Amentum has focused on its position in the commercial services space and how investors...

On March 11, 2026, shareholder John Chevedden submitted a proposal at The Sherwin-Williams Company to lower the ownership threshold required for investors to call a special shareholder meeting, while the board urged shareholders to vote against it at the April 22, 2026 annual meeting. This clash over special meeting rights highlights ongoing tension between Sherwin-Williams’ management and activist investors regarding how much direct influence shareholders should have over corporate...

Portnoy Law Firm has launched a securities fraud investigation into Cleveland-Cliffs (NYSE:CLF) following the company’s recent financial disclosure. Cleveland-Cliffs reported a revenue decline and larger than expected losses, alongside plans to idle six steel plants and exit loss-making business segments. The investigation is being framed as a potential class action on behalf of investors who experienced stock value losses. Cleveland-Cliffs, trading at about $8.46, has seen sharp share...

JOYY Inc. has reported its fourth-quarter and full-year 2025 results, returned to profitability, and reinforced shareholder payouts with a quarterly dividend program through 2027, an additional special dividend, and completion of a US$159.7 million share repurchase covering 5.54% of its shares. The combination of accelerating BIGO Ads growth, improving social entertainment operations, and sizable capital returns highlights how JOYY is reshaping its revenue mix while actively using its...

Century Communities' multifamily division, Century Living, has acquired a shovel-ready site in Denver's LoHi neighborhood for a luxury apartment project called The Stevie. Groundbreaking is set to begin imminently, with leasing currently projected to start in 2028. The Stevie represents an expansion for NYSE:CCS further into high-end multifamily development in a central Denver location. Century Communities, listed on the NYSE under ticker CCS, is primarily known for building single-family...

Why Coursera’s growth push is back in focus Recent commentary on Coursera (COUR) has zeroed in on its choice to prioritize user growth, with average revenue per customer falling 8.1% annually and estimates pointing to slower sales growth ahead. At the same time, Coursera is carrying high marketing expenses to keep attracting learners. This highlights a tension between expanding the platform and improving profitability that many investors are reassessing. See our latest analysis for...

If you are trying to figure out whether NewMarket's current share price fairly reflects its fundamentals, you are in the right place. The stock recently closed at US$584.66, after a 7 day return of an 8.8% decline, a 30 day return of a 16.2% decline, and a year to date return of a 15.0% decline, set against a 1 year return of 13.2%, a 3 year return of 78.2%, and a 5 year return of 66.4%. Recent coverage has focused on how NewMarket's share price performance over multiple time frames may...

If you are wondering whether Tyler Technologies is starting to look interesting at its current share price, this article will walk through what the numbers are saying about value. The stock closed at US$349.79 most recently, after a 6.6% decline over the last 7 days, a 3.1% gain over 30 days, and returns of 19.7% decline year to date and 37.9% decline over the past year. The 3 year and 5 year returns sit at 7.1% and 16.7% decline respectively. Recent coverage has continued to focus on Tyler...

If you are wondering whether Airbnb's share price still lines up with what the business is worth, this article will walk through how the numbers stack up and where the valuation questions really sit. Airbnb's stock last closed at US$126.30, with returns of 5.6% over the past 30 days, a 5.0% decline year to date, a 2.8% gain over 1 year, a 6.9% gain over 3 years and a 35.0% decline over 5 years. Taken together, these figures give a mixed picture of how the market has been updating its...